Document ID: chunk:federal_register_of_legislation:F2018L01746:clause:2_6
Version: federal_register_of_legislation:F2018L01746
Segment Type: clause
Provision Reference: sch 2 cl 6
Character Range: 5806–7037

6  Therapeutic goods information
 (1) The kinds of therapeutic goods information set out in Part 1 of Schedule 2 are specified for the purpose of subsection 61(5C) of the Act, in relation to a shortage of a reportable medicine in Australia that arises on or after 1 January 2019.
 (2) The kinds of therapeutic goods information set out in Part 2 of Schedule 2 are specified for the purpose of subsection 61(5C) of the Act, in relation to a decision to permanently discontinue the supply of a reportable medicine in Australia that is made on or after 1 January 2019.
 (3) The kinds of therapeutic goods information set out in Part 3 of Schedule 2 are specified for the purpose of subsection 61(5C) of the Act, in relation to a shortage of a medicine in Australia that arises before 1 January 2019.
 (4) The kinds of therapeutic goods information set out in Part 4 of Schedule 2 are specified for the purpose of subsection 61(5C) of the Act, in relation to a decision to permanently discontinue the supply of a medicine in Australia that is made before 1 January 2019.
Note: Kinds of therapeutic goods information specified under subsection 61(5D) of the Act may be released by the Secretary to the public under subsection 61(5C).